THEY’RE BACK!
April 12th, 2010 | Posted by CTL
Share This
FDA returned on April 8th to check up on CTL.
Hey FDA, any word on Provenge approval yet, or are you still using snow days as an excuse to deny the treatment to the men who so desperately need it.
You are welcome to our site anytime. We look forward to seeing you in person at our next demonstration, but until then, make yourself at home here.
Oh, and we are still awaiting a response to our letter to Josh Sharfstein. Could you remind him to give us a call?
Thanks Brenda!
Popularity: 24%
Tags: CareToLive, CTL, Dendreon, FDA, Howard Scher, Josh Sharfstein, Joshua Sharfstein, Prostate Cancer, provenge, Richard Pazdur

